{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:42:15Z","timestamp":1790854935366,"version":"4.1.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Following stress signals, the p53 tumor suppressor protein plays a critical role in regulation of cell proliferation, mainly through induction of growth arrest or apoptosis. Therefore, this protein needs to be strictly regulated and numerous studies have shown that the MDM2 protein is an essential element for p53 regulation in normal cells and, most importantly, that overexpression of MDM2 is responsible for p53 inactivation in various types of tumors. A previous study showed that this is the case in some Burkitt lymphoma (BL) cell lines, where enhanced translation of mdm2 messenger RNA results in overexpression of the protein that complexes and inactivates wild-type p53. To further investigate the role of the p53\/MDM2 complex in these BL cells, as well as in other lymphoid cells that do not overexpress MDM2, this study used antisense oligodeoxynucleotides directed either against mdm2 or against p53. Results show that the mdm2 antisense oligodeoxynucleotide induces apoptosis of cells that express a high or low level of MDM2 protein, only if they contain wild-type p53. Moreover, apoptosis is independent of the accumulation of p53 following mdm2 antisense treatment. Finally, the p53 antisense oligodeoxynucleotide, which inhibits the expression of wild-type p53, also induces a decrease of the MDM2 level in cells, whether or not they overexpress this protein, and causes apoptosis of these cells. These results indicate that decreasing the MDM2 protein level by directly or indirectly targeting its biosynthesis is a potent tool for the induction of apoptosis.<\/jats:p>","DOI":"10.1182\/blood.v97.4.1043","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"1043-1049","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides"],"prefix":"10.1182","volume":"97","author":[{"given":"Corinne","family":"Capoulade","sequence":"first","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis M.","family":"Mir","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Carlier","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Le\u0301cluse","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301cile","family":"Te\u0301taud","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohair","family":"Mishal","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe\u0308lle","family":"Wiels","sequence":"additional","affiliation":[{"name":"From the CNRS UMR 1598, Interactions mole\u0301culaires et cancer, Institut Gustave Roussy, Villejuif, France; Laboratoire de cytome\u0301trie, Institut de recherche sur le cancer, rue Guy Moquet, Villejuif, France; CNRS UMR 8532, Physicochimie et pharmacologie des macromole\u0301cules biologiques, Institut Gustave Roussy, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219175531500_B1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","article-title":"The p53 pathway.","volume":"187","author":"Prives","year":"1999","journal-title":"J Pathol."},{"key":"2020021219175531500_B2","first-page":"R43","article-title":"An insight into the life of p53: a protein coping with many functions! Review of the 9th p53 Workshop, Crete, May 9-13, 1998.","volume":"1378","author":"Almog","year":"1998","journal-title":"Biochim Biophys Acta."},{"key":"2020021219175531500_B3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.1998.0097","article-title":"Regulation of p53 downstream genes.","volume":"8","author":"el-Deiry","year":"1998","journal-title":"Semin Cancer Biol."},{"key":"2020021219175531500_B4","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res."},{"key":"2020021219175531500_B5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/26.1.205","article-title":"IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools.","volume":"26","author":"Hainaut","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"2020021219175531500_B6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01535205","article-title":"Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line.","volume":"13","author":"Cahilly-Snyder","year":"1987","journal-title":"Somat Cell Mol Genet."},{"key":"2020021219175531500_B7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/j.1460-2075.1991.tb07676.x","article-title":"Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.","volume":"10","author":"Fakharzadeh","year":"1991","journal-title":"EMBO J."},{"key":"2020021219175531500_B8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/MCB.13.1.301","article-title":"The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.","volume":"13","author":"Finlay","year":"1993","journal-title":"Mol Cell Biol."},{"key":"2020021219175531500_B9","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database.","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"2020021219175531500_B10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1101\/gad.11.6.714","article-title":"Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.","volume":"11","author":"Lundgren","year":"1997","journal-title":"Genes Dev."},{"key":"2020021219175531500_B11","doi-asserted-by":"crossref","first-page":"15608","DOI":"10.1073\/pnas.95.26.15608","article-title":"Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.","volume":"95","author":"Jones","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219175531500_B12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.onc.1201432","article-title":"Mdm2: keeping p53 under control.","volume":"15","author":"Piette","year":"1997","journal-title":"Oncogene."},{"key":"2020021219175531500_B13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199709051772","article-title":"The mdm2 proto-oncogene.","volume":"26","author":"Haines","year":"1997","journal-title":"Leuk Lymphoma."},{"key":"2020021219175531500_B14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s000180050273","article-title":"Functions of the MDM2 oncoprotein.","volume":"55","author":"Freedman","year":"1999","journal-title":"Cell Mol Life Sci."},{"key":"2020021219175531500_B15","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.","volume":"69","author":"Momand","year":"1992","journal-title":"Cell."},{"key":"2020021219175531500_B16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","article-title":"Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.","volume":"362","author":"Oliner","year":"1993","journal-title":"Nature."},{"key":"2020021219175531500_B17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/emboj\/17.2.554","article-title":"Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.","volume":"17","author":"Roth","year":"1998","journal-title":"EMBO J."},{"key":"2020021219175531500_B18","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.96.6.3077","article-title":"Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.","volume":"96","author":"Tao","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219175531500_B19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett."},{"key":"2020021219175531500_B20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/j.1460-2075.1993.tb05678.x","article-title":"Mdm2 expression is induced by wild-type p53 activity.","volume":"12","author":"Barak","year":"1993","journal-title":"EMBO J."},{"key":"2020021219175531500_B21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","article-title":"The p53-mdm2 autoregulatory feedback loop.","volume":"7","author":"Wu","year":"1993","journal-title":"Genes Dev."},{"key":"2020021219175531500_B22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/378203a0","article-title":"Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.","volume":"378","author":"Montes de Oca Luna","year":"1995","journal-title":"Nature."},{"key":"2020021219175531500_B23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/378206a0","article-title":"Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.","volume":"378","author":"Jones","year":"1995","journal-title":"Nature."},{"key":"2020021219175531500_B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma.","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv Cancer Res."},{"key":"2020021219175531500_B25","first-page":"223","article-title":"c-myc deregulation by chromosomal translocation in Burkitt's lymphoma.","volume-title":"Cellular Oncogene Activation.","author":"Bornkamm","year":"1988"},{"key":"2020021219175531500_B26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hon.2900090202","article-title":"Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature.","volume":"9","author":"Kornblau","year":"1991","journal-title":"Hematol Oncol."},{"key":"2020021219175531500_B27","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 in hematologic malignancies.","volume":"84","author":"Imamura","year":"1994","journal-title":"Blood."},{"key":"2020021219175531500_B28","first-page":"1633","article-title":"Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.","volume":"6","author":"Wiman","year":"1991","journal-title":"Oncogene."},{"key":"2020021219175531500_B29","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/j.1460-2075.1991.tb07837.x","article-title":"p53 is frequently mutated in Burkitt's lymphoma cell lines.","volume":"10","author":"Farrell","year":"1991","journal-title":"EMBO J."},{"key":"2020021219175531500_B30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1099\/0022-1317-74-5-803","article-title":"Biological activities of p53 mutants in Burkitt's lymphoma cells.","volume":"74","author":"Vousden","year":"1993","journal-title":"J Gen Virol."},{"key":"2020021219175531500_B31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1023\/A:1008265304712","article-title":"Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.","volume":"8","author":"Gutierrez","year":"1997","journal-title":"Ann Oncol."},{"key":"2020021219175531500_B32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.onc.1201702","article-title":"Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.","volume":"16","author":"Capoulade","year":"1998","journal-title":"Oncogene."},{"key":"2020021219175531500_B33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0042-6822(73)90163-3","article-title":"Transformation of rat cells by DNA of human adenovirus 5.","volume":"54","author":"Graham","year":"1973","journal-title":"Virology."},{"key":"2020021219175531500_B34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/375691a0","article-title":"Stimulation of E2F1\/DP1 transcriptional activity by MDM2 oncoprotein.","volume":"375","author":"Martin","year":"1995","journal-title":"Nature."},{"key":"2020021219175531500_B35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","article-title":"Amplification of a gene encoding a p53-associated protein in human sarcomas.","volume":"358","author":"Oliner","year":"1992","journal-title":"Nature."},{"key":"2020021219175531500_B36","first-page":"582","article-title":"The involvement of \u201ctumor suppressor\u201d p53 in normal and chronic myelogenous leukemia hemopoeisis.","volume":"54","author":"Bi","year":"1994","journal-title":"Cancer Res."},{"key":"2020021219175531500_B37","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1073\/pnas.84.21.7716","article-title":"Rearrangement of the p53 gene in human osteogenic sarcomas.","volume":"84","author":"Masuda","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219175531500_B38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2144\/98252gt04","article-title":"Highly efficient oligonucleotide transfer into intact yeast cells using square-wave pulse electroporation.","volume":"25","author":"Barre","year":"1998","journal-title":"Biotechniques."},{"key":"2020021219175531500_B39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-4157(93)90016-H","article-title":"Cell electropermeabilization: a new tool for biochemical and pharmacological studies.","volume":"1154","author":"Orlowski","year":"1993","journal-title":"Biochim Biophys Acta."},{"key":"2020021219175531500_B40","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/bjc.1998.388","article-title":"Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy.","volume":"77","author":"Mir","year":"1998","journal-title":"Br J Cancer."},{"key":"2020021219175531500_B41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00001813-199902000-00001","article-title":"Antitumor drug delivery by tissue electroporation.","volume":"10","author":"Singh","year":"1999","journal-title":"Anticancer Drugs."},{"key":"2020021219175531500_B42","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant.","volume":"273","author":"Oliver","year":"1998","journal-title":"J Biol Chem."},{"key":"2020021219175531500_B43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2.","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature."},{"key":"2020021219175531500_B44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53.","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature."},{"key":"2020021219175531500_B45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03402136","article-title":"Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression.","volume":"5","author":"Chen","year":"1999","journal-title":"Mol Med."},{"key":"2020021219175531500_B46","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V90.5.1982","article-title":"MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells.","volume":"90","author":"Teoh","year":"1997","journal-title":"Blood."},{"key":"2020021219175531500_B47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes p53: ARF-INF4a locus deletion impairs both the Rb and p53 tumor suppression pathways.","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell."},{"key":"2020021219175531500_B48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1097-2765(00)80309-3","article-title":"RB regulates the stability and the apoptotic function of p53 via MDM2.","volume":"3","author":"Hsieh","year":"1999","journal-title":"Mol Cell."},{"key":"2020021219175531500_B49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1097-2765(00)80140-9","article-title":"P300\/MDM2 complexes participate in MDM2-mediated p53 degradation.","volume":"2","author":"Grossman","year":"1998","journal-title":"Mol Cell."},{"key":"2020021219175531500_B50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0960-9822(06)00374-5","article-title":"Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.","volume":"7","author":"Bottger","year":"1997","journal-title":"Curr Biol."},{"key":"2020021219175531500_B51","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/sj.onc.1202528","article-title":"p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.","volume":"18","author":"Wasylyk","year":"1999","journal-title":"Oncogene."},{"key":"2020021219175531500_B52","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/sj.onc.1202781","article-title":"Mdm2 binds p73 alpha without targeting degradation.","volume":"18","author":"Balint","year":"1999","journal-title":"Oncogene."},{"key":"2020021219175531500_B53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1357-4310(98)01260-X","article-title":"Keeping an old friend under control: regulation of p53 stability.","volume":"4","author":"Kubbutat","year":"1998","journal-title":"Mol Med Today."},{"key":"2020021219175531500_B54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/gyno.1995.1272","article-title":"Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines.","volume":"59","author":"Janicek","year":"1995","journal-title":"Gynecol Oncol."},{"key":"2020021219175531500_B55","first-page":"277","article-title":"Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.","volume":"1","author":"Shohat","year":"1987","journal-title":"Oncogene."},{"key":"2020021219175531500_B56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10428199409059593","article-title":"Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences.","volume":"12","author":"Bayever","year":"1994","journal-title":"Leuk Lymphoma."},{"key":"2020021219175531500_B57","first-page":"1371","article-title":"Antisense RNA p53 inhibits proliferation of normal and transformed cells.","volume":"22","author":"Prasolov","year":"1988","journal-title":"Mol Biol (Mosk)."},{"key":"2020021219175531500_B58","first-page":"122","article-title":"Antisense p53 provokes changes in HeLa cell growth and morphology.","volume":"68","author":"Iotsova","year":"1995","journal-title":"Eur J Cell Biol."},{"key":"2020021219175531500_B59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1349-7006.1996.tb00286.x","article-title":"p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines.","volume":"87","author":"Hirota","year":"1996","journal-title":"Jpn J Cancer Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/4\/1043\/1671651\/h8040101043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/4\/1043\/1671651\/h8040101043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T01:01:01Z","timestamp":1581555661000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/4\/1043\/53144\/Apoptosis-of-tumoral-and-nontumoral-lymphoid-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,15]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.4.1043","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,15]]}}}